News Sentiment

IRMD sentiment intelligence

Iradimed Co news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 59 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 97.20 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-3.7% over one week, +3.8% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Should You Think About Buying IRADIMED CORPORATION (NASDAQ:IRMD) Now?

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -3.7% Price reacting lower
Trend fit Trend inactive 3.8% over four weeks
Fair value 61.2% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 42
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 13
TradingView 9
TradingKey 8
Stock Titan 5
simplywall.st 3
Finviz 2
StockStory 2
MT Newswires 2

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 19
Capital return 3
Analyst action 2
Regulatory and legal 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 59
TradingView Direct company coverage

Price to book forward of IRadimed Corp. – LS:A118V4

This article provides financial information for IRadimed Corp. (LS:A118V4), specifically focusing on its price-to-book forward ratio. It includes an overview of the company's financials on TradingView, such as market data provided by ICE Data Services and reference data from Fact

Tone
Neutral 50/100
Event
Market update
Published
05 Jul 2026 09:10
Source
TradingView
Finviz Direct company coverage

IRMD - Iradimed Corp Latest SEC Filings

This article provides the latest SEC filings and a comprehensive overview of Iradimed Corp (IRMD) financials and performance metrics. It details key financial figures such as market cap, income, sales, and various ratios, alongside stock performance, insider and institutional own

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 13:40
Source
Finviz
TradingView Direct company coverage

Price to book forward of IRadimed Corp. – HAN:46K

This article provides the "Price to book forward" metric for IRadimed Corp. (HAN:46K) trading on the Hannover Stock Exchange. It is a financial data point without further analysis or contextual information.

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 04:41
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of IRadimed Corp. – HAN:46K

This article presents the enterprise value to revenue forward for IRadimed Corp. (HAN:46K) as listed on the Hannover Stock Exchange. Although the article provides no specific numerical data, it frames the company's financial metric within the context of a stock exchange listing.

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 13:39
Source
TradingView
TradingView Direct company coverage

IRadimed Corp. Actuals & Estimates (DUS:46K)

This article provides an overview of IRadimed Corp. (DUS:46K) financial actuals and estimates, including income statement, balance sheet, and cash flow data. It covers analyst forecasts for the stock, historical price performance, upcoming earnings dates, and details on past earn

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 10:10
Source
TradingView
TradingView Direct company coverage

46K Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for IRadimed Corp. (46K) stock, based on analyst opinions. It includes details on maximum and minimum price estimates, past financial performance, upcoming earnings dates, dividend information, and company metrics like EBITDA and

Tone
Positive 64/100
Event
Analyst action
Published
26 Jun 2026 11:39
Source
TradingView
TradingView Direct company coverage

IRadimed Corp. Actuals & Estimates (NASDAQ:IRMD)

This article provides an overview of iRadimed Corporation (NASDAQ: IRMD) including financial actuals, estimates, and analyst forecasts. It covers key metrics like current stock price, historical highs and lows, market capitalization, earnings, revenue, dividends, and volatility,

Tone
Positive 76/100
Event
Earnings
Published
26 Jun 2026 09:10
Source
TradingView
Stock Titan Direct company coverage

Iradimed (NASDAQ: IRMD) investors approve directors, auditor and pay

Iradimed Corporation's shareholders held their annual meeting, where they elected Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel, and James Hawkins to the board of directors. They also approved RSM US LLP as the independent auditor for the fiscal year ending December 31

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 14:39
Source
Stock Titan
Investing.com Australia Direct company coverage

Form 4 Iradimed Co For: 23 June By Investing.com

This article from Investing.com is a regulatory filing update titled "Form 4 Iradimed Co For: 23 June." It reports on the Form 4 filing for Iradimed Co (IRMD) made on June 23rd, 2026, indicating insider transactions for the company. The article contains the title, publication dat

Tone
Neutral 50/100
Event
Regulatory and legal
Published
23 Jun 2026 23:09
Source
Investing.com Australia
Stock Titan Direct company coverage

IRADIMED (IRMD) CFO converts RSUs to stock and uses 2,319 shares for taxes

IRADIMED CFO John Glenn converted 5,796 restricted stock units (RSUs) into common shares on June 20, 2026. He then disposed of 2,319 shares to cover tax obligations, which was a tax-withholding transaction, not an open-market sale. Following these transactions, Glenn directly hol

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 13:10
Source
Stock Titan
Sahm Direct company coverage

IRADIMED (IRMD) Stock Could Be 21.9% Undervalued on Its MRI Pump Upgrade Narrative

IRADIMED (IRMD) is currently valued by one narrative as 21.9% undervalued at $92.20 per share, with a fair value target of $118, primarily due to the anticipated replacement cycle driven by its new 3870 MRI compatible IV pump. While this narrative projects significant revenue gro

Tone
Positive 71/100
Event
Analyst action
Published
22 Jun 2026 00:10
Source
Sahm
Intellectia AI Direct company coverage

IRMD Technical Analysis & Stock Price Forecast

The article provides a technical analysis and stock price forecast for IRadimed Corp (IRMD), indicating a "Strong Buy" consensus based on various technical indicators and moving averages. While some indicators like RSI are neutral or sell, the MACD and several moving averages sug

Tone
Positive 77/100
Event
Guidance
Published
18 Jun 2026 21:13
Source
Intellectia AI
TradingKey Direct company coverage

IRadimed Corp (IRMD) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for IRadimed Corp (IRMD), indicating an earnings forecast score of 8.00 and ranking 66th in its industry. Analysts, based on 2 ratings, have an average price target of $99.00 with a "Buy" recommendation. The company's previous quarter EP

Tone
Positive 76/100
Event
Earnings
Published
18 Jun 2026 20:11
Source
TradingKey
TradingKey Direct company coverage

IRadimed Corp (IRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for IRadimed Corp (IRMD), highlighting its current risk assessment score of 7.77 and ranking within the Healthcare Equipment & Supplies industry. It details various risk metrics including beta, maximum drawdown, volatility, and Sharpe Ratio

Tone
Negative 39/100
Event
Market update
Published
17 Jun 2026 21:40
Source
TradingKey
TradingKey Direct company coverage

IRadimed Corp (IRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a detailed historical overview of IRadimed Corp's (IRMD) dividend payouts, including future declared dividends. It lists the dividend amount, record date, payment date, and ex-dividend date for various interim and final cash dividends. The report also notes

Tone
Neutral 50/100
Event
Capital return
Published
17 Jun 2026 20:11
Source
TradingKey
TradingKey Direct company coverage

IRadimed Corp (IRMD) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of IRadimed Corp (IRMD), listing major individual and institutional holders. It provides a breakdown of shareholder types and traces institutional shareholding trends over several quarters. The data includes the proportion of shares

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 02:11
Source
TradingKey
TradingKey Direct company coverage

IRadimed Corp (IRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for IRadimed Corp (IRMD), categorizing its revenue by business segments and geographical regions. As of April 6, 2024, the company's largest revenue contributors are MRI Compatible IV Infusion Pump Systems and MRI Compatible Pati

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 02:11
Source
TradingKey
TradingKey Direct company coverage

IRadimed Corp (IRMD) Institutional Confidence

IRadimed Corp (IRMD) has an institutional shareholding score of 5.00, placing it 109th in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 65.08%, a 13.11% increase quarter-over-quarter. James Simons is the largest institutional sharehold

Tone
Positive 64/100
Event
Market update
Published
16 Jun 2026 20:09
Source
TradingKey
TradingKey Direct company coverage

IRadimed Corp (IRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of IRadimed Corp (IRMD), focusing on its support and resistance levels, various technical indicators, and moving averages. As of June 16, 2026, IRMD's price momentum score is 7.36, and the stock is trading between resistance at $98.06 an

Tone
Negative 40/100
Event
Market update
Published
16 Jun 2026 19:40
Source
TradingKey
TradingKey Direct company coverage

IRadimed Corp (IRMD) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial analysis of IRadimed Corp (IRMD), highlighting its strong financial health with a score of 9.60. The company ranks highly in its industry due to robust financial status, high operating efficiency, and significant year-over-year increases in reven

Tone
Positive 74/100
Event
Market update
Published
16 Jun 2026 07:40
Source
TradingKey
TradingView Direct company coverage

Number of shareholders of IRadimed Corp. – DUS:46K

The article displays an overview of IRadimed Corp. (DUS:46K) on the TradingView platform, focusing on the number of shareholders. It includes sections for financial data, news, community insights, forecasts, and stock information, indicating a market closed status with no recent

Tone
Neutral 50/100
Event
Market update
Published
06 Jun 2026 23:09
Source
TradingView
Finviz Direct company coverage

IRMD - Iradimed Corp Stock Price and Quote

This page provides a comprehensive overview of Iradimed Corp (IRMD) stock, including its latest closing price, dollar and percentage changes, and various financial metrics such as market cap, income, sales, and P/E ratio. It also details dividend information, employee count, IPO

Tone
Positive 78/100
Event
Capital return
Published
05 Jun 2026 15:10
Source
Finviz
Investing.com South Africa Direct company coverage

Iradimed director sells $285,000 in company stock By Investing.com

A director at IRADIMED CORP, Hilda Frederique Scharen-Guivel, sold 3,000 shares of company stock for $285,000 on June 4, 2026. This transaction occurred amidst a strong 52% return for IRMD stock over the past year, though InvestingPro's Fair Value analysis suggests the shares may

Tone
Negative 34/100
Event
Market update
Published
05 Jun 2026 04:40
Source
Investing.com South Africa